King's College London

King’s College London is one of the top 25 universities in the world (2016/17 QS World University Rankings) and is the largest healthcare learning centre in Europe, incorporating three teaching hospitals.

In the 2014 Research Excellence Framework, it was ranked 6th nationally in the ‘power’ ranking, which takes into account the quality and quantity of research activity, and ranks among the top institutions in the Times Higher Education (THE) World University Rankings.

The Division of Cancer Studies at King's College London is part of one of the leading cancer research centres in Europe: the King's Health Partners' Integrated Cancer Centre with expertise on cancer genomics, haemato-oncology, breast cancer biology, epidemiology, cancer cell biology and palliative care. The Division benefits from unique resources such as the Bio-Bank and the Thames Cancer Registry.

Role

King's College London will evaluate the iManageCancer platform as a whole with adult cancer patients, in collaboration with European Institute of Oncology and provide retrospective data from patients under chemotherapy to Philips for the development of a computational model for neutropenia prediction.


Twitter: @KingsEUresearch

Website

http://www.kcl.ac.uk/index.aspx